NCT00270400View on ClinicalTrials.gov

A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure

PHASE3CompletedINTERVENTIONAL

Enrollment

255

Participants

Timeline

Start Date

August 31, 1998

Study Completion Date

February 28, 1999

Conditions

Heart Failure, Congestive

Interventions

DRUG

nesiritide

All Listed Sponsors

lead

Scios, Inc.

INDUSTRY

NCT00270400 - A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure | Biotech Hunter | Biotech Hunter